Barretos Cancer Hospital
hospitaldeamor.com.brTotal trials
47
Active
3
Phase 3
5
Total enrollment
16,812
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Imiquimod | — | — | — | — | 2 |
Next readouts
- 2026-12-31
Top conditions
- Cervical Intraepithelial Neoplasia4
- Cancer3
- Breast Cancer3
- Biomarkers2
- Acute Kidney Injury2
- Anxiety Disorders2
- Colorectal Cancer2
- Cervical Cancer2
Frequently asked questions about Barretos Cancer Hospital
- How many clinical trials does Barretos Cancer Hospital have on ClinicalTrials.gov?
- Barretos Cancer Hospital is listed as the lead sponsor on 47 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Barretos Cancer Hospital's trials are in Phase 3?
- 5 of Barretos Cancer Hospital's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Barretos Cancer Hospital focus on?
- Barretos Cancer Hospital's most-studied conditions on ClinicalTrials.gov are Cervical Intraepithelial Neoplasia, Cancer, Breast Cancer, Biomarkers, Acute Kidney Injury.
- When are Barretos Cancer Hospital's next clinical trial readouts?
- Barretos Cancer Hospital has 1 upcoming primary-completion readout tracked here; the soonest is “Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod”, expected around 2026-12-31.